Research Expert: Sarah Overall
  • Published: Apr 2025
  • Pages: 150
  • SKU: IRTNTR45214

  • Latest News- Celiac Diseases Drugs Market: First line treatment is expected to lead the Therapy segment during 2025-2029

    The Celiac Diseases Drugs Market is being driven by Higher consumption of gluten-containing food

    The Celiac Diseases Drugs Market is expected to grow at a CAGR of 23.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1505 million. The celiac diseases drugs market is poised for expansion through strategic inorganic growth initiatives. These include mergers and acquisitions, partnerships, and regional acquisitions, which will boost research and development for new molecules and advance the clinical pipeline of celiac disease treatments. Notably, Takeda and Zedira's collaboration and licensing agreement for the investigational therapy ZED1227/TAK-227, a Phase 2b treatment for celiac disease, exemplifies this trend. Such strategic alliances will likely fortify market consolidation in the future. 

    Get more information on Celiac Diseases Drugs Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Therapy
      • First line treatment
      • Second-line treatment
    • Route Of Administration
      • Oral
      • Parenteral
    • Distribution Channel
      • Hospitals and specialty clinics
      • Specialty pharmacies
      • Retail pharmacies
      • Online platforms
    • Geography
      • North America
        • Canada
        • US
      • Europe
        • Germany
        • UK
        • France
        • Italy
      • Asia
        • China
        • India
        • Japan
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Higher consumption of gluten-containing food
      • Increasing prevalence of celiac diseases
      • Government initiatives

      However, the market also witnesses some limitations, which are as follows:

      • Poor diagnosis
      • Complexity of disease
      • Long-term sustainability

      Benefits of Buying Global Celiac Diseases Drugs Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Celiac Diseases Drugs Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      212

      Base year

      2024

      Historic period

      2019-2023

      Forecast period

      2025-2029

      Growth momentum & CAGR

      Accelerate at a CAGR of 23.6%

      Market growth 2025-2029

      USD 1505 million

      Market structure

      market_structure.ucfirst

      YoY growth 2024-2025(%)

      18.9

      Key countries

      US, Canada, Germany, UK, Italy, France, The Netherlands, China, Japan, and India

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      The Celiac Diseases Drugs Market is significantly influenced by various factors including the adoption of a gluten-free lifestyle, certification and labeling of gluten-free products, expansion of gluten-free restaurant options, and growth in gluten-free travel. Rising awareness, research, and funding from organizations like the Celiac Disease Foundation also impact the market. The gluten-free food industry continues to innovate, while understanding of celiac disease's epidemiology, prevalence, genetics, immunology, and pathophysiology advances. Celiac disease prognosis remains challenging, but ongoing research holds promise for improved treatments.

      Market Research Overview

      The Celiac Diseases Drugs Market is a significant segment of the global pharmaceuticals industry, encompassing companies involved in the research and development (R&D) or production of both generic and non-generic medications. According to Technavio, the global pharmaceuticals market size is determined by the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the growth of this market include the increasing global population aging, with approximately one-quarter of the US population projected to be over 60 years old by 2050, and Europe reaching a similar demographic milestone by 2030. This demographic shift is expected to fuel demand for various pharmaceutical products, including those used to treat Celiac Disease, Gluten Sensitivity, and Gluten Intolerance, as well as other health conditions prevalent among older populations.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.